| Saraswathi Ann Cappelle, DO | |
|
12902 Usf Magnolia Dr, Tampa, FL 33612-9416 | |
| (813) 745-0112 | |
| Not Available |
| Full Name | Saraswathi Ann Cappelle |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 12902 Usf Magnolia Dr, Tampa, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083977045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | OS019147 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Temple University Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Temple Faculty Practice Plan Inc | 0345588711 | 1063 |
News Archive
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
Researchers at the Beijing Computational Science Research Center and Peking University analyzed sequences of the angiotensin-converting enzyme 2 (ACE2) proteins from 16 mammals and predicted the structures of ACE2- receptor-binding domain (RBD) complexes.
I still think I had a pretty good idea for health reform — despite its rejection by significant Democratic and Republican leaders — but so did Bob Bennett. I was on the Senate floor three years ago when Bob walked across the center aisle to tell me he was willing to work with me on health reform (Sen. Ron Wyden, 5/21).
› Verified 5 days ago
| Entity Name | Fox Chase Cancer Center Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396019444 PECOS PAC ID: 8123289550 Enrollment ID: O20120412000054 |
News Archive
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
Researchers at the Beijing Computational Science Research Center and Peking University analyzed sequences of the angiotensin-converting enzyme 2 (ACE2) proteins from 16 mammals and predicted the structures of ACE2- receptor-binding domain (RBD) complexes.
I still think I had a pretty good idea for health reform — despite its rejection by significant Democratic and Republican leaders — but so did Bob Bennett. I was on the Senate floor three years ago when Bob walked across the center aisle to tell me he was willing to work with me on health reform (Sen. Ron Wyden, 5/21).
› Verified 5 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
Researchers at the Beijing Computational Science Research Center and Peking University analyzed sequences of the angiotensin-converting enzyme 2 (ACE2) proteins from 16 mammals and predicted the structures of ACE2- receptor-binding domain (RBD) complexes.
I still think I had a pretty good idea for health reform — despite its rejection by significant Democratic and Republican leaders — but so did Bob Bennett. I was on the Senate floor three years ago when Bob walked across the center aisle to tell me he was willing to work with me on health reform (Sen. Ron Wyden, 5/21).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Saraswathi Ann Cappelle, DO 12902 Usf Magnolia Dr, Tampa, FL 33612-9416 Ph: () - | Saraswathi Ann Cappelle, DO 12902 Usf Magnolia Dr, Tampa, FL 33612-9416 Ph: (813) 745-0112 |
News Archive
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Brain imaging soon after mild traumatic brain injury or mild concussion can detect tiny lesions that may eventually provide a target for treating people with mTBI, according to a study released today and that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
Researchers at the Beijing Computational Science Research Center and Peking University analyzed sequences of the angiotensin-converting enzyme 2 (ACE2) proteins from 16 mammals and predicted the structures of ACE2- receptor-binding domain (RBD) complexes.
I still think I had a pretty good idea for health reform — despite its rejection by significant Democratic and Republican leaders — but so did Bob Bennett. I was on the Senate floor three years ago when Bob walked across the center aisle to tell me he was willing to work with me on health reform (Sen. Ron Wyden, 5/21).
› Verified 5 days ago
Chhavi Gupta, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 508 S Habana Ave., Suite 270, Tampa, FL 33609 Phone: 813-388-1732 Fax: 813-864-9292 | |
Dr. Luis Leon Alvarado, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Va 111, Tampa, FL 33612 Phone: 813-972-2000 Fax: 813-631-3423 | |
Dr. Nirmal Shyam Sharma, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Tampa General Cir Fl Circle6, Tampa, FL 33606 Phone: 813-974-2201 | |
Aniqa Shahrier, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 3003 W Dr Martin Luther King Jr Blvd Fl 3, Tampa, FL 33607 Phone: 877-537-4787 | |
Sriprintha Navarathinarajah, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5130 Sunforest Dr Ste 300, Tampa, FL 33634 Phone: 727-824-0780 Fax: 813-514-8891 | |
Dr. Olga Kaliebe, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2919 W Swann Ave, Tampa, FL 33609 Phone: 813-392-1900 Fax: 813-392-1901 | |
William Dinwoodie, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 12902 Usf Magnolia Dr, Mdc 44, Tampa, FL 33612 Phone: 813-745-3980 Fax: 813-745-7229 |